Ignite Creation Date:
2024-05-06 @ 8:26 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06386744
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-26
First Post:
2024-04-23
Brief Title:
Dusquetide for the Treatment of Behcets Disease
Sponsor:
Soligenix
Organization:
Soligenix
Study Overview
Official Title:
Pilot Study of SGX945 Dusquetide in the Treatment of Aphthous Ulcers in Behcets Disease
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a clinical study to see if dusquetide can treat flares of oral and genital ulcers caused by Behcets Disease Study participants will receive an infusion of dusquetide twice a week for 4 weeks 8 treatments total with weekly follow-up visits for an additional 4 weeks
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None